News
Aubrey Barnett was diagnosed with a rare cancer, Burkitt lymphoma, as she started her senior year of high school. As she ...
Fred Hutch announces eight recipients of the 2025 Dr. Eddie Méndez Scholar Award, which honors exceptional postdoctoral researchers in the areas of cancer, infectious disease and basic science.
Globally, women are roughly twice as likely as men to be diagnosed with thyroid cancer. However, recent research shows that ...
Phase 2 study, led by Dr. Antonio Jimeno at the University of Colorado Anschutz Medical Campus will evaluate NT219 in ...
CHANCES ARE, ONE out of five of you reading this will be diagnosed with skin cancer by the time you hit age 70. As the most ...
Douglas Adkins, MD, discusses future directions of the KEYNOTE-689 trial of pembrolizumab in head and neck cancer following the agent's FDA approval.
Smoking, alcohol consumption and betel nut chewing are some of the lifestyle factors that have been linked to head and neck ...
1d
Pharmaceutical Technology on MSNFDA approves MSD’s Keytruda to treat head and neck cancerMSD has received US Food and Drug Administration (FDA) approval for its anti-programmed death receptor-1 (PD-1) therapy, ...
A Lampeter cancer nurse and international bowler has been named in the King's Birthday Honours List. Anwen Butten, a Head and ...
RaySearch Laboratories AB (publ) is pleased to announce that RayStation®*, its advanced treatment planning system, was used in the first European clinical treatments with Neutron Therapeutics' ...
Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...
A nurse was awarded an MBE in the 2025 King’s Birthday Honours because of her ‘truly inspiring’ work with patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results